Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Picoplatin in Refractory or Progressive SCLC (SPEAR)
NCT00465491Phase 3Unknown
- Sponsor
- Poniard Pharmaceuticals, Inc.
- Start
- Apr 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of picoplatin in small cell lung cancer (SCLC), sponsored by Poniard Pharmaceuticals, Inc.. Status: unknown.
02
Drugs
picoplatin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00465491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00465491.